Invention Grant
US07351792B2 Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
失效
重组C140受体,其激动剂和拮抗剂,以及编码受体的核酸
- Patent Title: Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
- Patent Title (中): 重组C140受体,其激动剂和拮抗剂,以及编码受体的核酸
-
Application No.: US10643627Application Date: 2003-08-19
-
Publication No.: US07351792B2Publication Date: 2008-04-01
- Inventor: Johan Sundelin , Robert M. Scarborough
- Applicant: Johan Sundelin , Robert M. Scarborough
- Applicant Address: US MA Cambridge
- Assignee: Millennium Pharmaceuticals, Inc.
- Current Assignee: Millennium Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Hoxie & Associates LLC
- Agent Thomas Hoxie
- Main IPC: C07K7/08
- IPC: C07K7/08 ; C07K7/00 ; C07K7/06 ; C07K14/705 ; C07K14/435 ; A61K38/00

Abstract:
Nucleic acid molecules encoding the C140 cell surface receptor have been cloned and sequenced. The availability of C140 receptor DNA permits the recombinant production of the C140 receptor which can be produced on the surface of a cell, including an oocyte. The nucleic acid molecules are useful in an assay for detecting a substance which affects C140 receptor activity, either receptor agonists or antagonists. Further, the elucidation of the structure of the C140 receptor permits the design of agonist and antagonist compounds which are useful in such assays. The availability of the C140 receptor also permits production of antibodies specifically immunoreactive with one or more antigenic epitopes of the C140 receptor.
Public/Granted literature
- US20050080234A1 Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor Public/Granted day:2005-04-14
Information query